Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | FYN | P06241 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CA3 | P07451 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6821782 | 1.00 | ALDH1A1 (0.39) | ALDH1A1MAPTSMN1; SMN2KDM4ENPC1 | |
| Bromide SCHEMBL15398508 | 0.98 | TSHR (0.38) | ALDH1A1MAPTSMN1; SMN2KDM4ENPC1 | |
| SCHEMBL31718392 | 0.83 | SIGMAR1 (0.37) | ALDH1A1MAPTSMN1; SMN2KDM4ELMNA | |
| SCHEMBL6880337 | 0.83 | HTR1A (0.47) | ALDH1A1MAPTSMN1; SMN2KDM4ENPC1 | |
| SCHEMBL6880115 | 0.79 | HTR1A (0.41) | ALDH1A1MAPTKDM4ELMNATDP1 | |
| SCHEMBL10333062 | 0.79 | ALDH1A1 (0.42) | ALDH1A1MAPTSMN1; SMN2KDM4ENPC1 | |
| SCHEMBL387883 | 0.79 | ALDH1A1 (0.42) | ALDH1A1MAPTSMN1; SMN2KDM4ENPC1 | |
| SCHEMBL5164785 | 0.78 | HSD17B10 (0.42) | ALDH1A1MAPTSMN1; SMN2KDM4ENPC1 | |
| SCHEMBL4630050 | 0.78 | ALDH1A1 (0.41) | ALDH1A1MAPTNPC1RAB9ATSHR | |
| SCHEMBL2204568 | 0.77 | LMNA (0.39) | ALDH1A1MAPTSMN1; SMN2KDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1304486-C | Phthalocyanine compound, process for producing the same, and optical recording medium containing the same | MITSUI CHEMICALS INC (JP) | 2007-03-14 | — | — | CN | claimed |
| CN-1170812-C | Method for synthesizing diphenyl-keto-acid derivative | 上海麦普化工有限公司 | 2004-10-13 | — | — | CN | claimed |
| CN-1354168-A | Method for synthesizing diphenyl-keto-acid derivative | SHANGHAI MAIPU CHEMICAL INDUST (CN) | 2002-06-19 | — | — | CN | claimed |
| US-20210078989-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | CHANGCHUN HYPERIONS TECHNOLOGY CO., LTD (CN) | 2021-03-18 | — | — | US | disclosed |
| CN-105264021-B | Hydrophobic inorganic particles, resin composition for heat dissipation member, electronic component device, and method for producing hydrophobic inorganic particles | 住友电木株式会社 | 2018-04-10 | — | — | CN | disclosed |
| CN-105246983-B | Hydrophobic inorganic particles, resin composition for heat-dissipating member, and electronic component device | 住友电木株式会社 | 2017-10-24 | — | — | CN | disclosed |
| EP-2656410-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2017-07-05 | — | — | EP | disclosed |
| WO-2012084115-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2012-06-28 | — | — | WO | disclosed |
| US-20090181413-A1 | SIMULTANEOUS AND DIFFERENTIAL QUANTIFICATION OF TWO TARGET ANALYTES IN BIOLOGICAL SAMPLE | DENKA SEIKEN CO., LTD. | 2009-07-16 | — | — | US | disclosed |
| EP-1930443-A1 | METHOD FOR SELECTIVE, SIMULTANEOUS QUANTIFICATION OF TWO SUBSTANCES IN BIOLOGICAL SAMPLE | DENKA SEIKEN Co., Ltd. (JP) | 2008-06-11 | — | — | EP | disclosed |
| US-7332261-B2 | Phthalocyanine compound, process for preparing the same, and optical recording medium containing the same | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-02-19 | — | — | US | disclosed |
| CN-1170812-C | Method for synthesizing diphenyl-keto-acid derivative | 上海麦普化工有限公司 | 2004-10-13 | — | — | CN | disclosed |
| US-6498245-B2 | A CARRIER WHICH COMPRISES A BASE MATERIAL AND A COMPOUND HAVING ONE OR MORE ALKYLATING GROUPS AND THE NUCLEIC ACIDS ARE IMMOBILIZED IN MULTI DOT LIKE AREAS ON CARRIER THROUGH INTERMEDIARY OF ALKYLATING GROUPS | NISSHINBO INDUSTRIES, INC. (JP) | 2002-12-24 | — | — | US | disclosed |
| CN-1354168-A | Method for synthesizing diphenyl-keto-acid derivative | SHANGHAI MAIPU CHEMICAL INDUST (CN) | 2002-06-19 | — | — | CN | disclosed |
| US-20010003649-A1 | Nucleic acid-immobilized substrate | NISSHINBO INDUSTRIES, INC. (JP) | 2001-06-14 | — | — | US | disclosed |
| EP-1104687-A2 | Nucleic acid-immobilized substrate | NISSHINBO INDUSTRIES, INC. (JP) | 2001-06-06 | — | — | EP | disclosed |
| EP-0114374-B1 | SUBSTITUTED 4-AMINOMETHYLENE CHROMANS OR CHROMENES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN MEDICINES | BAYER AG (DE) | 1986-07-23 | — | — | EP | disclosed |
| EP-0114374-A1 | Substituted 4-aminomethylene chromans or chromenes, process for their preparation and their use in medicines | BAYER AG (DE) | 1984-08-01 | — | — | EP | disclosed |
| US-4381265-A | Aromatic nitrile-containing compounds useful as dyestuff intermediates | MILLIKEN RESEARCH CORPORATION (US) | 1983-04-26 | — | — | US | disclosed |
| US-4330476-A | CONDENSATION OF AROMATIC ALDEHYDE WITH AROMATIC AMINE FOLLOWED BY OXIDATION | BAYER AKTIENGESELLSCHAFT (DE) | 1982-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010003649-A1 | Nucleic acid-immobilized substrate | DNMT1, DNMT3A, DNMT3L | ALDH1A1 1236/4885MAPT 3705/4885SMN1; SMN2 1167/4885 |
| US-20210078989-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | SOX18, TYR, L1CAM | ALDH1A1 1610/4885MAPT 985/4885SMN1; SMN2 2991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.